Cutler Group LP Adicet Bio, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Cutler Group LP holds 100 shares of ACET stock, worth $109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$109% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ACET
# of Institutions
72Shares Held
59.2MCall Options Held
4.2KPut Options Held
6.7K-
Orbimed Advisors LLC San Diego, CA11.4MShares$12.5 Million0.39% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$8.96 Million1.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$8.22 Million0.15% of portfolio
-
Goldman Sachs Group Inc New York, NY3.76MShares$4.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.49 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $43.6M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...